Metastatic bone disease – online course
Please note that this course is no longer CME accredited, but we are working on a new accredited version.
Authors: F. Deschamps and B. Gonçalves
Reviewers: M. Deutschmann, F. Fanelli, D. Filippiadis, L. Kamper and C. Nice
This course corresponds to chapter 22.214.171.124 Fundamental IO in the European Curriculum and Syllabus for IR.
Bone is the third most common site for metastasis. Metastatic bone disease is predominantly found in the central bones of the body, most commonly in the spine but also in the pelvis (hip bone), proximal femur, humerus, ribs and in the skull. Metastatic bone sites are rarely able to be cured because of a major component: the bone marrow that acts as an easy deposit and a way of spread into other tissues. Thus, finding and treating bone metastases early can help prevent other problems later in the disease as well as the patient performance status (PST).
- Know which techniques must be used for the treatment of bone metastases according to the clinical presentation
- Understand the different mechanisms of pain in patients suffering from bone metastases
- How to choose the right materials to perform a correct, easy and safe bone access
- Know the indication and the limits of cementoplasty for bone metastases
- Understand the rational for “augmented” cementoplasty compared to cementoplasty alone and know when it should be used
- Know the differences between ablative techniques and their limitations
- How to achieve a good outcomes according to different ablation techniques
This course covers a basic level of IR knowledge and is designed for trainees, students or young consultants aiming to acquire essential knowledge or prepare for the EBIR exam. Thereby, it is tailored to the European Curriculum and Syllabus for IR and corresponds to chapter 126.96.36.199 Fundamental IO.
The format of the course is easy to use and interactive by including texts, graphics, videos and a quiz to support your learning. The course duration is around one hour
Upon purchase, access to the course is granted for an enrolment period of 90 days.
Release date: November 2018